Rongna Ma, Yuning Liu, Hong Liu, Zhong Xu, Xiaofei Wu, Yao Jia, Yuwen Huang, Qin Mo, Xun Wang
Background and Objectives: While there exists a significant wastage of platelets on one side (volatile demands and short lifetime), there is also a shortage for use on the other (lack of donors and emergency transfusions). A new centralized management system was established to tackle this dilemma. Methods: To assess the function of this system, data were collected from the Fengxian Blood Bank (FBB) Collection and Supply Information System during 2016 and 2018, then analyzed by IBM SPSS Statistics version 20. Results: Since implementing the centralized management system, a total of 1340 units of apheresis platelets were distributed by FBB. However, the number of units collected was 2737, twice as much as what had been distributed. With the aid of the system, the excess of 1644 units of apheresis platelets were transferred to the Shanghai Blood Center (SBC) inventory at their disposal. On the other hand, 247 units (included in 1340 distributed units) were compensated by SBC during the platelet shortage. In addition, the hospital demand meeting rate shows a significant increase from 82.61% to 99.78%, especially for type AB which increases from 62% to 100%. Conclusions: In conclusion, the centralized management system vastly improved the efficiency of platelet collection and distribution by the regional supply and demand. Such success would be a superb example of blood banks facing similar problems.
{"title":"Pilot study of centralized management system in Shanghai: A promising solution to platelet collection and supply imbalance in small blood banks","authors":"Rongna Ma, Yuning Liu, Hong Liu, Zhong Xu, Xiaofei Wu, Yao Jia, Yuwen Huang, Qin Mo, Xun Wang","doi":"10.4103/gjtm.gjtm_31_23","DOIUrl":"https://doi.org/10.4103/gjtm.gjtm_31_23","url":null,"abstract":"Background and Objectives: While there exists a significant wastage of platelets on one side (volatile demands and short lifetime), there is also a shortage for use on the other (lack of donors and emergency transfusions). A new centralized management system was established to tackle this dilemma. Methods: To assess the function of this system, data were collected from the Fengxian Blood Bank (FBB) Collection and Supply Information System during 2016 and 2018, then analyzed by IBM SPSS Statistics version 20. Results: Since implementing the centralized management system, a total of 1340 units of apheresis platelets were distributed by FBB. However, the number of units collected was 2737, twice as much as what had been distributed. With the aid of the system, the excess of 1644 units of apheresis platelets were transferred to the Shanghai Blood Center (SBC) inventory at their disposal. On the other hand, 247 units (included in 1340 distributed units) were compensated by SBC during the platelet shortage. In addition, the hospital demand meeting rate shows a significant increase from 82.61% to 99.78%, especially for type AB which increases from 62% to 100%. Conclusions: In conclusion, the centralized management system vastly improved the efficiency of platelet collection and distribution by the regional supply and demand. Such success would be a superb example of blood banks facing similar problems.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"397 1","pages":"133 - 138"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139365323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Basavarajegowda, J. Gnanaraj, Rajendra Gurunath Kulkarni, D. Sahoo
Background and Objectives: During a surgical or medical emergency, the timely issue of crossmatched blood is crucial for efficient and satisfactory patient revival. Turnaround time (TAT) is the duration taken from the time blood requests, and samples are received in the blood center until the blood is crossmatched and available for blood transfusion. The study aimed to audit the TAT in our center, analyze and study the factors delaying TAT, and formulate plans to improve it by implementing corrective measures. These actions would directly or indirectly impact the outcomes of the delivery of patient care in emergency services. Methods: A record-based prospective study was performed in a tertiary care teaching hospital with trauma and all emergency services in Southwestern India. TAT was calculated for all emergency blood requests received over 16 months in a systematic sampling method. Cases with prolonged TATs, where the product issue TAT exceeded the internal policy and quality indicator standards (15 min for emergency packed red blood cells issue), were further evaluated for causes of delay and analyzed at frequent intervals. Results: The mean TAT at the start of the study was 17.1 min (standard deviation [SD] 1.05 min), gradually reducing to 14.9 min (SD 0.62 min) by the end of the study, and it was statistically significant with P = 0.01. Conclusion: It is essential to deduce the causes for delayed TAT and work on those variables amenable to modifications based on priority to improve the TAT regarding pretransfusion testing and the issue of blood products, which is crucial in emergency services.
背景与目的：在外科或内科急诊中，及时发放交叉配血对于高效、满意地救治病人至关重要。周转时间（TAT）是指从血液中心收到血液申请和样本到血液交叉配血并可用于输血所需的时间。本研究旨在对本中心的周转时间进行审计，分析和研究延迟周转时间的因素，并制定计划，通过实施纠正措施来改善周转时间。这些措施将直接或间接地影响急诊服务中患者护理的结果。研究方法在印度西南部一家提供创伤和所有急诊服务的三级医疗教学医院开展了一项基于记录的前瞻性研究。采用系统抽样方法计算了 16 个月内收到的所有急诊用血申请的 TAT。对于产品发放 TAT 超过内部政策和质量指标标准（急诊包装红细胞发放时间为 15 分钟）的超长 TAT 病例，将进一步评估延误原因并定期进行分析。结果：研究开始时的平均 TAT 为 17.1 分钟（标准差 [SD] 1.05 分钟），研究结束时逐渐缩短至 14.9 分钟（标准差 0.62 分钟），P = 0.01，具有统计学意义。结论有必要推断出 TAT 延迟的原因，并根据优先顺序对那些可修改的变量进行修改，以改善输血前检测和血液制品问题方面的 TAT，这对急诊服务至关重要。
{"title":"Improving turnaround time for the issue of blood components in case of emergency","authors":"A. Basavarajegowda, J. Gnanaraj, Rajendra Gurunath Kulkarni, D. Sahoo","doi":"10.4103/gjtm.gjtm_17_23","DOIUrl":"https://doi.org/10.4103/gjtm.gjtm_17_23","url":null,"abstract":"Background and Objectives: During a surgical or medical emergency, the timely issue of crossmatched blood is crucial for efficient and satisfactory patient revival. Turnaround time (TAT) is the duration taken from the time blood requests, and samples are received in the blood center until the blood is crossmatched and available for blood transfusion. The study aimed to audit the TAT in our center, analyze and study the factors delaying TAT, and formulate plans to improve it by implementing corrective measures. These actions would directly or indirectly impact the outcomes of the delivery of patient care in emergency services. Methods: A record-based prospective study was performed in a tertiary care teaching hospital with trauma and all emergency services in Southwestern India. TAT was calculated for all emergency blood requests received over 16 months in a systematic sampling method. Cases with prolonged TATs, where the product issue TAT exceeded the internal policy and quality indicator standards (15 min for emergency packed red blood cells issue), were further evaluated for causes of delay and analyzed at frequent intervals. Results: The mean TAT at the start of the study was 17.1 min (standard deviation [SD] 1.05 min), gradually reducing to 14.9 min (SD 0.62 min) by the end of the study, and it was statistically significant with P = 0.01. Conclusion: It is essential to deduce the causes for delayed TAT and work on those variables amenable to modifications based on priority to improve the TAT regarding pretransfusion testing and the issue of blood products, which is crucial in emergency services.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"178 1","pages":"182 - 185"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139364611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Raturi, B. Adhikari, Y. Dhiman, D. Gaur, A. Kusum
Background and Objectives: Uttarakhand, a state in northern India, is home to various local communities, including the Garhwali, Kumaoni, and Jaunsari. In addition, individuals from neighboring countries such as Nepal and Tibet reside in Uttarakhand for many years, resulting in a diverse population. However, currently, there is no regional registry for rare blood donors in this state. The aim of this study was to develop a rare donor registry in Uttarakhand which could in future become a part of the national rare blood donor registry. Methods: During the routine donation process, samples were taken from randomly selected O-typed blood donors who are residents of Uttarakhand. Seventeen monoclonal antisera included Rh (anti-D, anti-C, anti-c, anti-E, and anti-e), Duffy (anti-Fya and anti-Fyb), Kell (anti-K and anti-k), Kidd (anti-Jka and anti-Jkb), Lewis (anti-Lea and anti-Leb), M, N, S, and s (Ortho Diagnostics Pvt Ltd, Mumbai, India). Furthermore, four polyclonal antisera from our serum repository, Diego (anti-Dia), Indian (anti-Ina), Rh (anti-Cw), and anti-Gp-Mur were used for phenotyping. The study was financially aided by the Uttarakhand State Council of Science and Technology (UCOST), Dehradun, Uttarakhand, Government of India. Results: Over a period of 16 months (November 2021–February 2023), out of a total of 17,004 blood donations, O blood type donors accounted for 29.9% (5085/17,004) of the donors screened. Among these, 7.3% (374/5085) of the donors were from the interior and plain areas of Uttarakhand. Our study revealed a high prevalence of k and e antigens, with 96.7% and 92.5%, respectively. The least prevalent antigen was Rh (Cw), observed in only 0.5% of cases. We also identified rare blood antigens such as Diego, Indian, and Gp-Mur and compared our findings with other studies. Furthermore, we identified a donor with an H-deficient phenotype, specifically the Bombay blood group (Oho). Conclusion: We have successfully established a regional registry for rare blood donors in Uttarakhand, which will be valuable for managing complex transfusion scenarios in the future. Further, given Uttarakhand's proximity to China and Nepal, the presence of individuals from these countries aptly connects the fields of anthropology and transfusion medicine.
背景与目标：北阿坎德邦是印度北部的一个邦，居住着各种当地社区，包括 Garhwali、Kumaoni 和 Jaunsari。此外，来自尼泊尔和西藏等邻国的人也常年居住在北阿坎德邦，从而形成了一个多样化的人口群体。然而，目前该邦还没有地区性的稀有献血者登记册。这项研究的目的是在北阿坎德邦建立一个稀有献血者登记处，将来成为全国稀有献血者登记处的一部分。方法：在常规献血过程中，从北阿坎德邦居民中随机抽取 O 型献血者样本。17 种单克隆抗血清包括 Rh（抗-D、抗-C、抗-E 和抗-e）、Duffy（抗-Fya 和抗-Fyb）、Kell（抗-K 和抗-k）、Kidd（抗-Jka 和抗-Jkb）、Lewis（抗-Lea 和抗-Leb）、M、N、S 和 s（Ortho Diagnostics Pvt Ltd，印度孟买）。此外，我们还使用了血清库中的四种多克隆抗血清：Diego（抗-Dia）、Indian（抗-Ina）、Rh（抗-Cw）和抗-Gp-Mur，用于表型分析。本研究得到了印度政府北阿坎德邦德拉敦的北阿坎德邦科技委员会（Uttarakhand State Council of Science and Technology, UCOST）的资助。研究结果在为期 16 个月（2021 年 11 月至 2023 年 2 月）的时间里，在总共 17004 名献血者中，O 型血献血者占筛选献血者的 29.9%（5085/17004）。其中，7.3%（374/5085）的献血者来自北阿坎德邦的内陆和平原地区。我们的研究显示，k 抗原和 e 抗原的流行率很高，分别为 96.7% 和 92.5%。发病率最低的抗原是 Rh 抗原（Cw），仅占 0.5%。我们还发现了迭戈、印度和 Gp-Mur 等罕见的血液抗原，并将我们的发现与其他研究进行了比较。此外，我们还发现了一名 H 抗原缺乏的捐献者，特别是孟买血型（Oho）。结论：我们成功地在北阿坎德邦建立了一个地区性稀有血型献血者登记处，这对今后管理复杂的输血情况非常有价值。此外，由于北阿坎德邦毗邻中国和尼泊尔，来自这些国家的献血者恰好将人类学和输血医学领域联系在一起。
{"title":"Establishing a regional rare blood donor registry in Uttarakhand, India","authors":"M. Raturi, B. Adhikari, Y. Dhiman, D. Gaur, A. Kusum","doi":"10.4103/gjtm.gjtm_28_23","DOIUrl":"https://doi.org/10.4103/gjtm.gjtm_28_23","url":null,"abstract":"Background and Objectives: Uttarakhand, a state in northern India, is home to various local communities, including the Garhwali, Kumaoni, and Jaunsari. In addition, individuals from neighboring countries such as Nepal and Tibet reside in Uttarakhand for many years, resulting in a diverse population. However, currently, there is no regional registry for rare blood donors in this state. The aim of this study was to develop a rare donor registry in Uttarakhand which could in future become a part of the national rare blood donor registry. Methods: During the routine donation process, samples were taken from randomly selected O-typed blood donors who are residents of Uttarakhand. Seventeen monoclonal antisera included Rh (anti-D, anti-C, anti-c, anti-E, and anti-e), Duffy (anti-Fya and anti-Fyb), Kell (anti-K and anti-k), Kidd (anti-Jka and anti-Jkb), Lewis (anti-Lea and anti-Leb), M, N, S, and s (Ortho Diagnostics Pvt Ltd, Mumbai, India). Furthermore, four polyclonal antisera from our serum repository, Diego (anti-Dia), Indian (anti-Ina), Rh (anti-Cw), and anti-Gp-Mur were used for phenotyping. The study was financially aided by the Uttarakhand State Council of Science and Technology (UCOST), Dehradun, Uttarakhand, Government of India. Results: Over a period of 16 months (November 2021–February 2023), out of a total of 17,004 blood donations, O blood type donors accounted for 29.9% (5085/17,004) of the donors screened. Among these, 7.3% (374/5085) of the donors were from the interior and plain areas of Uttarakhand. Our study revealed a high prevalence of k and e antigens, with 96.7% and 92.5%, respectively. The least prevalent antigen was Rh (Cw), observed in only 0.5% of cases. We also identified rare blood antigens such as Diego, Indian, and Gp-Mur and compared our findings with other studies. Furthermore, we identified a donor with an H-deficient phenotype, specifically the Bombay blood group (Oho). Conclusion: We have successfully established a regional registry for rare blood donors in Uttarakhand, which will be valuable for managing complex transfusion scenarios in the future. Further, given Uttarakhand's proximity to China and Nepal, the presence of individuals from these countries aptly connects the fields of anthropology and transfusion medicine.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"24 1","pages":"176 - 181"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139365742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dorota Kubicka-Russel, Aneta Kopacz, Ewa Sulkowska, Magdalena Łętowska, Piotr Grabarczyk
Wstęp: Dotychczas wykazano, że częstość zakażeń wśród dawców zakwalifikowanych do oddania krwi i objętych badaniami przeglądowymi, a w konsekwencji ryzyko powikłań potransfuzyjnych wiążą się z charakterystyką demograficzną dawców. Celem pracy było ustalenie zmian demograficznych wśród polskich dawców zakwalifikowanych w latach 2005–2018 do oddania krwi i objętych badaniami przeglądowymi w kierunku czynników zakaźnych. Uzyskane wyniki interpretowano w kontekście bezpieczeństwa transfuzji, a zwłaszcza ryzyka przenoszenia czynników zakaźnych przez krew. Materiał i metody: Analizowano dane gromadzone między innymi do oceny epidemiologii czynników zakaźnych przenoszonych przez krew: liczbę przebadanych dawców zakwalifikowanych do oddania krwi z podziałem na płeć, dawców pierwszorazowych i wielokrotnych oraz grupy wiekowe (≤ 20, 21–30, 31–40, 41–50, 51–60 i > 60 lat). Częstość (frakcję) wyrażano w procentach z 95-procentowym przedziałem ufności [95%CI], a różnice za pomocą punktu procentowego (p.p.). Istotność różnic (p < 0,05) weryfikowano za pomocą testu Chi-kwadrat, do oceny trendu stosowano współczynnik korelacji Spearmana (R). Wyniki: Większość dawców stanowili mężczyźni (średnio 74,07%), jednak w latach 2005–2012 udział kobiet wzrósł o 7 p.p. do 27,42% [27,30–27,53%] (p < 0,05); wśród dawców pierwszorazowych o 10,58 p.p., a wielokrotnych o 7,19 p.p. Największy udział kobiet obserwowano wśród najmłodszych dawców (36,02% [35,95–36,09%]), a najniższy wśród najstarszych dawców (14,14% [13,80–14,48%]) (różnica 21,88 p.p.; p < 0,05). Większość dawców krwi stanowili dawcy wielokrotni (średnio 66,78%). Udział dawców wielokrotnych wzrósł łącznie o 19,83 p.p. (p < 0,05): o 20,6 p.p. u mężczyzn i 21,15 p.p. u kobiet (dla obu grup p < 0,05). We wszystkich grupach wiekowych, z wyjątkiem dawców najmłodszych, większość (p < 0,05) stanowili dawcy wielokrotni. Udział dawców wielokrotnych rósł w kolejnych grupach wiekowych — od 36% u najmłodszych (≤ 20 lat) do 87% u dawców najstarszych (> 60 lat). Udział dawców w wieku > 40 lat zwiększył się o 11,58 p.p od 37,38% do 48,96%. Wnioski: W latach 2005–2018 obserwowano istotne zmiany demograficzne w grupie polskich dawców zakwalifikowanych do oddania krwi i objętych badaniami przeglądowymi, m.in. wzrósł udział kobiet oraz dawców wielokrotnych, co z punktu widzenia bezpieczeństwa transfuzji jest zjawiskiem korzystnym.
{"title":"Zmiany demograficzne obserwowane w grupie polskich dawców zakwalifikowanych do oddania krwi i objętych badaniami przeglądowymi w kierunku czynników zakaźnych w latach 2005-2018","authors":"Dorota Kubicka-Russel, Aneta Kopacz, Ewa Sulkowska, Magdalena Łętowska, Piotr Grabarczyk","doi":"10.5603/jtm.95751","DOIUrl":"https://doi.org/10.5603/jtm.95751","url":null,"abstract":"Wstęp: Dotychczas wykazano, że częstość zakażeń wśród dawców zakwalifikowanych do oddania krwi i objętych badaniami przeglądowymi, a w konsekwencji ryzyko powikłań potransfuzyjnych wiążą się z charakterystyką demograficzną dawców. Celem pracy było ustalenie zmian demograficznych wśród polskich dawców zakwalifikowanych w latach 2005–2018 do oddania krwi i objętych badaniami przeglądowymi w kierunku czynników zakaźnych. Uzyskane wyniki interpretowano w kontekście bezpieczeństwa transfuzji, a zwłaszcza ryzyka przenoszenia czynników zakaźnych przez krew. Materiał i metody: Analizowano dane gromadzone między innymi do oceny epidemiologii czynników zakaźnych przenoszonych przez krew: liczbę przebadanych dawców zakwalifikowanych do oddania krwi z podziałem na płeć, dawców pierwszorazowych i wielokrotnych oraz grupy wiekowe (≤ 20, 21–30, 31–40, 41–50, 51–60 i > 60 lat). Częstość (frakcję) wyrażano w procentach z 95-procentowym przedziałem ufności [95%CI], a różnice za pomocą punktu procentowego (p.p.). Istotność różnic (p < 0,05) weryfikowano za pomocą testu Chi-kwadrat, do oceny trendu stosowano współczynnik korelacji Spearmana (R). Wyniki: Większość dawców stanowili mężczyźni (średnio 74,07%), jednak w latach 2005–2012 udział kobiet wzrósł o 7 p.p. do 27,42% [27,30–27,53%] (p < 0,05); wśród dawców pierwszorazowych o 10,58 p.p., a wielokrotnych o 7,19 p.p. Największy udział kobiet obserwowano wśród najmłodszych dawców (36,02% [35,95–36,09%]), a najniższy wśród najstarszych dawców (14,14% [13,80–14,48%]) (różnica 21,88 p.p.; p < 0,05). Większość dawców krwi stanowili dawcy wielokrotni (średnio 66,78%). Udział dawców wielokrotnych wzrósł łącznie o 19,83 p.p. (p < 0,05): o 20,6 p.p. u mężczyzn i 21,15 p.p. u kobiet (dla obu grup p < 0,05). We wszystkich grupach wiekowych, z wyjątkiem dawców najmłodszych, większość (p < 0,05) stanowili dawcy wielokrotni. Udział dawców wielokrotnych rósł w kolejnych grupach wiekowych — od 36% u najmłodszych (≤ 20 lat) do 87% u dawców najstarszych (> 60 lat). Udział dawców w wieku > 40 lat zwiększył się o 11,58 p.p od 37,38% do 48,96%. Wnioski: W latach 2005–2018 obserwowano istotne zmiany demograficzne w grupie polskich dawców zakwalifikowanych do oddania krwi i objętych badaniami przeglądowymi, m.in. wzrósł udział kobiet oraz dawców wielokrotnych, co z punktu widzenia bezpieczeństwa transfuzji jest zjawiskiem korzystnym.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136367131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Impact of proliferative stress on both adaptive and innate immune response","authors":"M. Czarnogórski, J. Witkowski, J. M. Zaucha","doi":"10.5603/jtm.2023.0004","DOIUrl":"https://doi.org/10.5603/jtm.2023.0004","url":null,"abstract":"","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82952855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dorota Kubicka‐Russel, Aneta Kopacz, E. Sulkowska, M. Łętowska, P. Grabarczyk
{"title":"Demographic changes in the Polish blood donors eligible for blood donation and screened for transfusion-transmitted infections (2005–2018)","authors":"Dorota Kubicka‐Russel, Aneta Kopacz, E. Sulkowska, M. Łętowska, P. Grabarczyk","doi":"10.5603/jtm.2023.0005","DOIUrl":"https://doi.org/10.5603/jtm.2023.0005","url":null,"abstract":"","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91194761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Innovative applications of platelet derivatives in light of information presented during the 2022 virtual congress of the International Society of Blood Transfusion (ISBT); selected issues","authors":"Paulina Goczyńska, Joanna Lasocka, E. Lachert","doi":"10.5603/jtm.2023.0003","DOIUrl":"https://doi.org/10.5603/jtm.2023.0003","url":null,"abstract":"","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83759866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"What’s new in the field of serum-based eye drops","authors":"","doi":"10.5603/jtm.2023.0002","DOIUrl":"https://doi.org/10.5603/jtm.2023.0002","url":null,"abstract":"","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77196499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.4103/2468-8398.376689
Shivaram Chandrashekar
{"title":"Donor confidentiality and privacy: Need of the hour in this era of digitalization","authors":"Shivaram Chandrashekar","doi":"10.4103/2468-8398.376689","DOIUrl":"https://doi.org/10.4103/2468-8398.376689","url":null,"abstract":"","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"25 1","pages":"1 - 3"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72767055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：